by Tony Akiwumi | Nov 11, 2025 | Pharma / Market Access
Every organisation wants strategic clarity. Consultants, executives, and boards all insist on it. Clarity feels safe. It looks rational. It fills slides beautifully. Yet clarity alone changes nothing. Without courage, even the best strategy becomes decoration. I once...
by Tony Akiwumi | Nov 11, 2025 | Pharma / Market Access
Inclusion is one of the most powerful forces in modern leadership. It encourages diversity of thought, unlocks creativity, and builds trust. Yet, like every virtue, it has a shadow. When inclusion turns into indecision, it becomes avoidance dressed as fairness. I have...
by Tony Akiwumi | Nov 11, 2025 | Pharma / Market Access
Collaboration has become the great corporate virtue. Entire departments are now built around it. Job descriptions, value statements, and leadership frameworks all celebrate teamwork and inclusivity. But behind the language of cooperation lies a quieter truth few...
by Tony Akiwumi | Nov 11, 2025 | Pharma / Market Access
A few years ago, I was in a strategy meeting that should have been electric. Smart people. Big ambitions. The sort of agenda that promised “transformation”. Except no one was talking. The most senior leader in the room laid out a complex plan and asked, “Thoughts?”...
by Tony Akiwumi | Nov 11, 2025 | Pharma / Market Access
Two days ago, I wrote about a situation that made me both laugh and wince. When I, yes it was me, sent a message to a hiring manager about a senior role application. My note was polite, thoughtful, and full of strategic insights and ideas for the role. The hiring...
by Tony Akiwumi | Nov 10, 2025 | Pharma / Market Access
A friend of mine, and I want to be clear that it was definitely not me, recently applied for a senior executive role. The job description asked for someone innovative, strategic, and proactive. They might as well have printed my friend’s name in the margin. True to...
